Tongyuan Kang Pharmaceutical-B Chairman Plans Up To HK$2 Million Share Purchases

Tongyuan Kang Pharmaceutical-B (02410) said Chairman, Executive Director and President Wu Yusheng recently bought shares in the open market and may continue to do so depending on market conditions, with the total planned increase currently capped at HK$2 million, according to ETNet. The company said Wu has pledged that shares acquired through any further purchases within the next month will be voluntarily locked up for six months from each purchase date and will not be sold during the lock-up period. Wu said the funds for the purchases come from his own resources and reflect his confidence in the group's future development prospects.